News

Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what ...
Kenvue says that CEO Thibaut Mongon is departing as the maker of Listerine and Band-Aid brands continues with a strategic ...
American consumer health company Kenvue's Board of Directors announced new actions to unlock shareholder value and an interim ...
Kenvue's has fired CEO Thibaut Mongon, who has also stepped down from the board, the consumer health company said on Monday, ...
The Johnson & Johnson spinoff that makes Tylenol and Benadryl, said Chief Executive Thibaut Mongon has departed and that the ...
Kenvue Inc. (NYSE: KVUE) is one of the stocks on Jim Cramer’s radar. During the episode, Cramer discussed the company’s ...
Kenvue appoints Kirk Perry as interim CEO after Thibaut Mongon's exit and launches strategic review to simplify operations.
The 12-month price targets, analyzed by analysts, offer insights with an average target of $23.58, a high estimate of $25.00, ...
With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is ...
Kenvue’s board of directors are considering ‘a broad range of potential alternatives’ and are hunting for a permanent ...
Kenvue Inc. closed 13.19% below its 52-week high of $25.17, which the company achieved on May 8th.